Perry C. Siatis - 03 Apr 2023 Form 4 Insider Report for AbbVie Inc. (ABBV)

Role
EVP, GC AND SECRETARY
Signature
Steven L. Scrogham, attorney-in-fact for Perry C. Siatis
Issuer symbol
ABBV
Transactions as of
03 Apr 2023
Net transactions value
-$563,200
Form type
4
Filing time
05 Apr 2023, 17:00:12 UTC
Previous filing
02 Mar 2023
Next filing
06 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABBV Common Stock, $0.01 par value Options Exercise $372,838 +3,520 +34% $105.92 13,897 03 Apr 2023 Direct
transaction ABBV Common Stock, $0.01 par value Sale $563,200 -3,520 -25% $160.00 10,377 03 Apr 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABBV Option (Right to buy) Options Exercise $372,838 -3,520 -50% $105.92 3,520 03 Apr 2023 Common Stock 3,520 $105.92 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

Remarks:

The option exercise and sale transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).